Day: March 8, 2022

MINNEAPOLIS, March 08, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it will host a conference call on March 24, 2022 at 4:30 PM Eastern Time to discuss results for its fourth quarter ended December 31, 2021. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Date: March 24, 2022Time: 4:30 PM Eastern TimeToll Free: 888-506-0062; Access Code: 461101International: 973-528-0011; Access Code: 461101 The call will also be available over the Internet and accessible at: https://www.webcaster4.com/Webcast/Page/2556/44452 Conference Call Replay Information Toll Free: 877-481-4010International: 919-882-2331Replay...

SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Astra Energy Inc. (OTC Pink Sheets: ASRE) (“Astra” or the “Company”), today announces the Company has engaged the government of Tanzania in discussions to construct a significantly sized, combined cycle power plant using natural gas as feedstock. Following meetings last week with the Tanzania Electric Supply Company Ltd. (TANESCO), the country’s vertically integrated electricity utility company, TANESCO provided a formal letter authorizing Astra to prepare a Project Concept Note. The Project Concept Note will provide salient key technical and financial parameters of the proposed project. It will be reviewed for approval by TANESCO and the Ministry of Energy and is the key piece of information used by the Government of Tanzania to trigger a detailed Memorandum...

NORTH BILLERICA, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the Barclays Global Healthcare Conference at 8:30 a.m. ET on Tuesday, March 15 in Miami, FL. To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for 30 days following the live presentation. About Lantheus Holdings, Inc. Lantheus Holdings,...

LAKE OSWEGO,OR, March 08, 2022 (GLOBE NEWSWIRE) — PSYC Corporation (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging medicinal psychedelics sector, and authorities behind Psychedelic Spotlight, a top ranking psychedelic news and information platform, is pleased to announce that the Company incorporated Spotlight Media Corporation (“Spotlight Media Corp.,” “SMC”), a wholly owned subsidiary of PSYC, with the intent of more effectively positioning the Company to expand on its existing media ventures both within, and potentially outside, of the medicinal psychedelic industry. Since launching Psychedelic Spotlight in 2020, the Company contends it established a significantly valuable foothold within the burgeoning psychedelics industry and emerged as a recognized leader in the production of premium, industry-focused...

IRVING, Texas, March 08, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), announced today that directors, executive officers and affiliates have informed that Company that they intend to tender in the aggregate over 5 million shares of common stock in the pending exchange offer. That total includes 1,528,160 shares of common stock that the Company’s Executive Chairman, Par Chadha, intends to tender. The Corporate Actions department at your broker can initiate the tender process. If you are having difficulty instructing your broker, you may contact D.F. King & Co., Inc., the information agent for the Offer, for assistance by calling toll-free: (888) 644-6071 or visit https://to.exelatech.com/ for this purpose. The Exchange Offer will expire at 11:59 p.m., New York City time, on March...

FREDERICK, Md., March 08, 2022 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes in disinfection and decontamination through the utilization of its premier Binary Ionization Technology (BIT) platform, announced that it has partnered with ARM EnerTech Associates, LLC, a U.S.-based engineering services & custom control panel manufacturer, to further develop its SteraMist brand of products. TOMI expects this partnership with ARM EnerTech Associates will enhance product development and expand the Company’s manufacturing capabilities. With 40 plus years of technical expertise, ARM EnerTech Associates is an ISO 9001:2015 quality certified provider of electrical and mechanical engineering, automation & controls, substation & power distribution design, UL508...

The companies have begun the Collaboration with a joint pre-clinical study and are expecting its results potentially to deepen the Collaboration between the parties. TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced a Collaboration agreement (the “Collaboration”) with SciSparc Ltd. (NASDAQ: SPRC). The two companies will explore the potential for the creation of innovative compounds in the psychedelic area. The Collaboration will address, inter alia, examining the benefit of integrating the core technologies of each company by combining molecules from their respective development...

Bag-in-Box Placement at All Business Center Sites Expands New Channel for Fountain Business SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) — Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), the original craft soda known for its unconventional flavors and user-designed label artwork, today announced that it has secured a new placement for its Root Beer bag-in-box (BIB) cane sugar syrup with all Costco Business Centers across the U.S., further expanding the company’s presence in the foodservice channel. The listing introduces the Jones fountain beverage program to Costco’s large members-only wholesale clientele, including restaurants, bars, convenience stores, offices, and other businesses in need of fountain beverage supplies. Placement of the three-gallon BIBs marks the first time that Jones Soda has secured nationwide...

Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report second quarter 2022 financial results on Monday, March 14, 2022, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time. Monday, March 14th  @ 4:30 pm ETDomestic:                    877-407-0792International:               201-689-8263Conference ID:           13727738 Webcast:                     Registration Link — Click Here About Enzo Biochem  Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic...

BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination with Libtayo for the treatment of advanced non-small cell lung cancer (NSCLC) The development costs for the trials will be equally shared between the parties The companies advance clinical development of FixVac and Libtayo combination to third tumor type building on their existing agreements in melanoma and prostate cancer by combining their complementary immunotherapies to pave the way for new treatment options in high medical need indicationsMAINZ, Germany, March 8, 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo® (cemiplimab), a PD-1...